Global Vaccine Adjuvants Market Analysis and Forecast 2024-2030
Summary
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, The global Vaccine Adjuvants market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vaccine Adjuvants, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccine Adjuvants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.
Vaccine Adjuvants segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Vaccine Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine Adjuvants sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, The global Vaccine Adjuvants market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Vaccine Adjuvants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Vaccine Adjuvants, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccine Adjuvants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccine Adjuvants sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine Adjuvants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Vaccine Adjuvants sales, projected growth trends, production technology, application and end-user industry.
Vaccine Adjuvants segment by Company
- GSK
- CSL Limited
- Croda
- SEPPIC
- Novavax
- SPI Pharma
- Phibro
- SDA BIO
- Invivogen
- Tj Kaiwei
- OZ Biosciences
- Brenntag Biosector
- MVP Laboratories
- Zhuoyue
- Aphios
- Aluminum Adjuvant
- Emulsions Adjuvant
- Others
- Human Vaccine
- Veterinary Vaccine
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Vaccine Adjuvants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccine Adjuvants sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Vaccine Adjuvants Market by Type
1.2.1 Global Vaccine Adjuvants Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Vaccine Adjuvants Market by Application
1.3.1 Global Vaccine Adjuvants Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 VACCINE ADJUVANTS MARKET DYNAMICS
2.1 Vaccine Adjuvants Industry Trends
2.2 Vaccine Adjuvants Industry Drivers
2.3 Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Vaccine Adjuvants Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Vaccine Adjuvants Revenue Estimates and Forecasts (2019-2030)
3.2 Global Vaccine Adjuvants Revenue by Region
3.2.1 Global Vaccine Adjuvants Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Vaccine Adjuvants Revenue by Region (2019-2024)
3.2.3 Global Vaccine Adjuvants Revenue by Region (2025-2030)
3.2.4 Global Vaccine Adjuvants Revenue Market Share by Region (2019-2030)
3.3 Global Vaccine Adjuvants Sales Estimates and Forecasts 2019-2030
3.4 Global Vaccine Adjuvants Sales by Region
3.4.1 Global Vaccine Adjuvants Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Vaccine Adjuvants Sales by Region (2019-2024)
3.4.3 Global Vaccine Adjuvants Sales by Region (2025-2030)
3.4.4 Global Vaccine Adjuvants Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Vaccine Adjuvants Revenue by Manufacturers
4.1.1 Global Vaccine Adjuvants Revenue by Manufacturers (2019-2024)
4.1.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Vaccine Adjuvants Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Vaccine Adjuvants Sales by Manufacturers
4.2.1 Global Vaccine Adjuvants Sales by Manufacturers (2019-2024)
4.2.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Vaccine Adjuvants Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Vaccine Adjuvants Sales Price by Manufacturers (2019-2024)
4.4 Global Vaccine Adjuvants Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Vaccine Adjuvants Manufacturers, Product Type & Application
4.7 Global Vaccine Adjuvants Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Vaccine Adjuvants Market CR5 and HHI
4.8.2 2023 Vaccine Adjuvants Tier 1, Tier 2, and Tier
5 VACCINE ADJUVANTS MARKET BY TYPE
5.1 Global Vaccine Adjuvants Revenue by Type
5.1.1 Global Vaccine Adjuvants Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Vaccine Adjuvants Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
5.2 Global Vaccine Adjuvants Sales by Type
5.2.1 Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Vaccine Adjuvants Sales by Type (2019-2030) & (MT)
5.2.3 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
5.3 Global Vaccine Adjuvants Price by Type
6 VACCINE ADJUVANTS MARKET BY APPLICATION
6.1 Global Vaccine Adjuvants Revenue by Application
6.1.1 Global Vaccine Adjuvants Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Vaccine Adjuvants Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
6.2 Global Vaccine Adjuvants Sales by Application
6.2.1 Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Vaccine Adjuvants Sales by Application (2019-2030) & (MT)
6.2.3 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
6.3 Global Vaccine Adjuvants Price by Application
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 GSK Vaccine Adjuvants Product Portfolio
7.1.5 GSK Recent Developments
7.2 CSL Limited
7.2.1 CSL Limited Comapny Information
7.2.2 CSL Limited Business Overview
7.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
7.2.5 CSL Limited Recent Developments
7.3 Croda
7.3.1 Croda Comapny Information
7.3.2 Croda Business Overview
7.3.3 Croda Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Croda Vaccine Adjuvants Product Portfolio
7.3.5 Croda Recent Developments
7.4 SEPPIC
7.4.1 SEPPIC Comapny Information
7.4.2 SEPPIC Business Overview
7.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
7.4.5 SEPPIC Recent Developments
7.5 Novavax
7.5.1 Novavax Comapny Information
7.5.2 Novavax Business Overview
7.5.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Novavax Vaccine Adjuvants Product Portfolio
7.5.5 Novavax Recent Developments
7.6 SPI Pharma
7.6.1 SPI Pharma Comapny Information
7.6.2 SPI Pharma Business Overview
7.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
7.6.5 SPI Pharma Recent Developments
7.7 Phibro
7.7.1 Phibro Comapny Information
7.7.2 Phibro Business Overview
7.7.3 Phibro Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Phibro Vaccine Adjuvants Product Portfolio
7.7.5 Phibro Recent Developments
7.8 SDA BIO
7.8.1 SDA BIO Comapny Information
7.8.2 SDA BIO Business Overview
7.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
7.8.5 SDA BIO Recent Developments
7.9 Invivogen
7.9.1 Invivogen Comapny Information
7.9.2 Invivogen Business Overview
7.9.3 Invivogen Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Invivogen Vaccine Adjuvants Product Portfolio
7.9.5 Invivogen Recent Developments
7.10 Tj Kaiwei
7.10.1 Tj Kaiwei Comapny Information
7.10.2 Tj Kaiwei Business Overview
7.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
7.10.5 Tj Kaiwei Recent Developments
7.11 OZ Biosciences
7.11.1 OZ Biosciences Comapny Information
7.11.2 OZ Biosciences Business Overview
7.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
7.11.5 OZ Biosciences Recent Developments
7.12 Brenntag Biosector
7.12.1 Brenntag Biosector Comapny Information
7.12.2 Brenntag Biosector Business Overview
7.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
7.12.5 Brenntag Biosector Recent Developments
7.13 MVP Laboratories
7.13.1 MVP Laboratories Comapny Information
7.13.2 MVP Laboratories Business Overview
7.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
7.13.5 MVP Laboratories Recent Developments
7.14 Zhuoyue
7.14.1 Zhuoyue Comapny Information
7.14.2 Zhuoyue Business Overview
7.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
7.14.5 Zhuoyue Recent Developments
7.15 Aphios
7.15.1 Aphios Comapny Information
7.15.2 Aphios Business Overview
7.15.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Aphios Vaccine Adjuvants Product Portfolio
7.15.5 Aphios Recent Developments
8 NORTH AMERICA
8.1 North America Vaccine Adjuvants Market Size by Type
8.1.1 North America Vaccine Adjuvants Revenue by Type (2019-2030)
8.1.2 North America Vaccine Adjuvants Sales by Type (2019-2030)
8.1.3 North America Vaccine Adjuvants Price by Type (2019-2030)
8.2 North America Vaccine Adjuvants Market Size by Application
8.2.1 North America Vaccine Adjuvants Revenue by Application (2019-2030)
8.2.2 North America Vaccine Adjuvants Sales by Application (2019-2030)
8.2.3 North America Vaccine Adjuvants Price by Application (2019-2030)
8.3 North America Vaccine Adjuvants Market Size by Country
8.3.1 North America Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Vaccine Adjuvants Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Vaccine Adjuvants Market Size by Type
9.1.1 Europe Vaccine Adjuvants Revenue by Type (2019-2030)
9.1.2 Europe Vaccine Adjuvants Sales by Type (2019-2030)
9.1.3 Europe Vaccine Adjuvants Price by Type (2019-2030)
9.2 Europe Vaccine Adjuvants Market Size by Application
9.2.1 Europe Vaccine Adjuvants Revenue by Application (2019-2030)
9.2.2 Europe Vaccine Adjuvants Sales by Application (2019-2030)
9.2.3 Europe Vaccine Adjuvants Price by Application (2019-2030)
9.3 Europe Vaccine Adjuvants Market Size by Country
9.3.1 Europe Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Vaccine Adjuvants Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Vaccine Adjuvants Market Size by Type
10.1.1 China Vaccine Adjuvants Revenue by Type (2019-2030)
10.1.2 China Vaccine Adjuvants Sales by Type (2019-2030)
10.1.3 China Vaccine Adjuvants Price by Type (2019-2030)
10.2 China Vaccine Adjuvants Market Size by Application
10.2.1 China Vaccine Adjuvants Revenue by Application (2019-2030)
10.2.2 China Vaccine Adjuvants Sales by Application (2019-2030)
10.2.3 China Vaccine Adjuvants Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Vaccine Adjuvants Market Size by Type
11.1.1 Asia Vaccine Adjuvants Revenue by Type (2019-2030)
11.1.2 Asia Vaccine Adjuvants Sales by Type (2019-2030)
11.1.3 Asia Vaccine Adjuvants Price by Type (2019-2030)
11.2 Asia Vaccine Adjuvants Market Size by Application
11.2.1 Asia Vaccine Adjuvants Revenue by Application (2019-2030)
11.2.2 Asia Vaccine Adjuvants Sales by Application (2019-2030)
11.2.3 Asia Vaccine Adjuvants Price by Application (2019-2030)
11.3 Asia Vaccine Adjuvants Market Size by Country
11.3.1 Asia Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Vaccine Adjuvants Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Vaccine Adjuvants Market Size by Type
12.1.1 MEALA Vaccine Adjuvants Revenue by Type (2019-2030)
12.1.2 MEALA Vaccine Adjuvants Sales by Type (2019-2030)
12.1.3 MEALA Vaccine Adjuvants Price by Type (2019-2030)
12.2 MEALA Vaccine Adjuvants Market Size by Application
12.2.1 MEALA Vaccine Adjuvants Revenue by Application (2019-2030)
12.2.2 MEALA Vaccine Adjuvants Sales by Application (2019-2030)
12.2.3 MEALA Vaccine Adjuvants Price by Application (2019-2030)
12.3 MEALA Vaccine Adjuvants Market Size by Country
12.3.1 MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Vaccine Adjuvants Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Vaccine Adjuvants Value Chain Analysis
13.1.1 Vaccine Adjuvants Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Vaccine Adjuvants Production Mode & Process
13.2 Vaccine Adjuvants Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Vaccine Adjuvants Distributors
13.2.3 Vaccine Adjuvants Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Vaccine Adjuvants Market by Type
1.2.1 Global Vaccine Adjuvants Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Vaccine Adjuvants Market by Application
1.3.1 Global Vaccine Adjuvants Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 VACCINE ADJUVANTS MARKET DYNAMICS
2.1 Vaccine Adjuvants Industry Trends
2.2 Vaccine Adjuvants Industry Drivers
2.3 Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Vaccine Adjuvants Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Vaccine Adjuvants Revenue Estimates and Forecasts (2019-2030)
3.2 Global Vaccine Adjuvants Revenue by Region
3.2.1 Global Vaccine Adjuvants Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Vaccine Adjuvants Revenue by Region (2019-2024)
3.2.3 Global Vaccine Adjuvants Revenue by Region (2025-2030)
3.2.4 Global Vaccine Adjuvants Revenue Market Share by Region (2019-2030)
3.3 Global Vaccine Adjuvants Sales Estimates and Forecasts 2019-2030
3.4 Global Vaccine Adjuvants Sales by Region
3.4.1 Global Vaccine Adjuvants Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Vaccine Adjuvants Sales by Region (2019-2024)
3.4.3 Global Vaccine Adjuvants Sales by Region (2025-2030)
3.4.4 Global Vaccine Adjuvants Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Vaccine Adjuvants Revenue by Manufacturers
4.1.1 Global Vaccine Adjuvants Revenue by Manufacturers (2019-2024)
4.1.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Vaccine Adjuvants Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Vaccine Adjuvants Sales by Manufacturers
4.2.1 Global Vaccine Adjuvants Sales by Manufacturers (2019-2024)
4.2.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Vaccine Adjuvants Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Vaccine Adjuvants Sales Price by Manufacturers (2019-2024)
4.4 Global Vaccine Adjuvants Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Vaccine Adjuvants Manufacturers, Product Type & Application
4.7 Global Vaccine Adjuvants Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Vaccine Adjuvants Market CR5 and HHI
4.8.2 2023 Vaccine Adjuvants Tier 1, Tier 2, and Tier
5 VACCINE ADJUVANTS MARKET BY TYPE
5.1 Global Vaccine Adjuvants Revenue by Type
5.1.1 Global Vaccine Adjuvants Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Vaccine Adjuvants Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
5.2 Global Vaccine Adjuvants Sales by Type
5.2.1 Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Vaccine Adjuvants Sales by Type (2019-2030) & (MT)
5.2.3 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
5.3 Global Vaccine Adjuvants Price by Type
6 VACCINE ADJUVANTS MARKET BY APPLICATION
6.1 Global Vaccine Adjuvants Revenue by Application
6.1.1 Global Vaccine Adjuvants Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Vaccine Adjuvants Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
6.2 Global Vaccine Adjuvants Sales by Application
6.2.1 Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Vaccine Adjuvants Sales by Application (2019-2030) & (MT)
6.2.3 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
6.3 Global Vaccine Adjuvants Price by Application
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 GSK Vaccine Adjuvants Product Portfolio
7.1.5 GSK Recent Developments
7.2 CSL Limited
7.2.1 CSL Limited Comapny Information
7.2.2 CSL Limited Business Overview
7.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
7.2.5 CSL Limited Recent Developments
7.3 Croda
7.3.1 Croda Comapny Information
7.3.2 Croda Business Overview
7.3.3 Croda Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Croda Vaccine Adjuvants Product Portfolio
7.3.5 Croda Recent Developments
7.4 SEPPIC
7.4.1 SEPPIC Comapny Information
7.4.2 SEPPIC Business Overview
7.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
7.4.5 SEPPIC Recent Developments
7.5 Novavax
7.5.1 Novavax Comapny Information
7.5.2 Novavax Business Overview
7.5.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Novavax Vaccine Adjuvants Product Portfolio
7.5.5 Novavax Recent Developments
7.6 SPI Pharma
7.6.1 SPI Pharma Comapny Information
7.6.2 SPI Pharma Business Overview
7.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
7.6.5 SPI Pharma Recent Developments
7.7 Phibro
7.7.1 Phibro Comapny Information
7.7.2 Phibro Business Overview
7.7.3 Phibro Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Phibro Vaccine Adjuvants Product Portfolio
7.7.5 Phibro Recent Developments
7.8 SDA BIO
7.8.1 SDA BIO Comapny Information
7.8.2 SDA BIO Business Overview
7.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
7.8.5 SDA BIO Recent Developments
7.9 Invivogen
7.9.1 Invivogen Comapny Information
7.9.2 Invivogen Business Overview
7.9.3 Invivogen Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Invivogen Vaccine Adjuvants Product Portfolio
7.9.5 Invivogen Recent Developments
7.10 Tj Kaiwei
7.10.1 Tj Kaiwei Comapny Information
7.10.2 Tj Kaiwei Business Overview
7.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
7.10.5 Tj Kaiwei Recent Developments
7.11 OZ Biosciences
7.11.1 OZ Biosciences Comapny Information
7.11.2 OZ Biosciences Business Overview
7.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
7.11.5 OZ Biosciences Recent Developments
7.12 Brenntag Biosector
7.12.1 Brenntag Biosector Comapny Information
7.12.2 Brenntag Biosector Business Overview
7.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
7.12.5 Brenntag Biosector Recent Developments
7.13 MVP Laboratories
7.13.1 MVP Laboratories Comapny Information
7.13.2 MVP Laboratories Business Overview
7.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
7.13.5 MVP Laboratories Recent Developments
7.14 Zhuoyue
7.14.1 Zhuoyue Comapny Information
7.14.2 Zhuoyue Business Overview
7.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
7.14.5 Zhuoyue Recent Developments
7.15 Aphios
7.15.1 Aphios Comapny Information
7.15.2 Aphios Business Overview
7.15.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Aphios Vaccine Adjuvants Product Portfolio
7.15.5 Aphios Recent Developments
8 NORTH AMERICA
8.1 North America Vaccine Adjuvants Market Size by Type
8.1.1 North America Vaccine Adjuvants Revenue by Type (2019-2030)
8.1.2 North America Vaccine Adjuvants Sales by Type (2019-2030)
8.1.3 North America Vaccine Adjuvants Price by Type (2019-2030)
8.2 North America Vaccine Adjuvants Market Size by Application
8.2.1 North America Vaccine Adjuvants Revenue by Application (2019-2030)
8.2.2 North America Vaccine Adjuvants Sales by Application (2019-2030)
8.2.3 North America Vaccine Adjuvants Price by Application (2019-2030)
8.3 North America Vaccine Adjuvants Market Size by Country
8.3.1 North America Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Vaccine Adjuvants Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Vaccine Adjuvants Market Size by Type
9.1.1 Europe Vaccine Adjuvants Revenue by Type (2019-2030)
9.1.2 Europe Vaccine Adjuvants Sales by Type (2019-2030)
9.1.3 Europe Vaccine Adjuvants Price by Type (2019-2030)
9.2 Europe Vaccine Adjuvants Market Size by Application
9.2.1 Europe Vaccine Adjuvants Revenue by Application (2019-2030)
9.2.2 Europe Vaccine Adjuvants Sales by Application (2019-2030)
9.2.3 Europe Vaccine Adjuvants Price by Application (2019-2030)
9.3 Europe Vaccine Adjuvants Market Size by Country
9.3.1 Europe Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Vaccine Adjuvants Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Vaccine Adjuvants Market Size by Type
10.1.1 China Vaccine Adjuvants Revenue by Type (2019-2030)
10.1.2 China Vaccine Adjuvants Sales by Type (2019-2030)
10.1.3 China Vaccine Adjuvants Price by Type (2019-2030)
10.2 China Vaccine Adjuvants Market Size by Application
10.2.1 China Vaccine Adjuvants Revenue by Application (2019-2030)
10.2.2 China Vaccine Adjuvants Sales by Application (2019-2030)
10.2.3 China Vaccine Adjuvants Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Vaccine Adjuvants Market Size by Type
11.1.1 Asia Vaccine Adjuvants Revenue by Type (2019-2030)
11.1.2 Asia Vaccine Adjuvants Sales by Type (2019-2030)
11.1.3 Asia Vaccine Adjuvants Price by Type (2019-2030)
11.2 Asia Vaccine Adjuvants Market Size by Application
11.2.1 Asia Vaccine Adjuvants Revenue by Application (2019-2030)
11.2.2 Asia Vaccine Adjuvants Sales by Application (2019-2030)
11.2.3 Asia Vaccine Adjuvants Price by Application (2019-2030)
11.3 Asia Vaccine Adjuvants Market Size by Country
11.3.1 Asia Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Vaccine Adjuvants Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Vaccine Adjuvants Market Size by Type
12.1.1 MEALA Vaccine Adjuvants Revenue by Type (2019-2030)
12.1.2 MEALA Vaccine Adjuvants Sales by Type (2019-2030)
12.1.3 MEALA Vaccine Adjuvants Price by Type (2019-2030)
12.2 MEALA Vaccine Adjuvants Market Size by Application
12.2.1 MEALA Vaccine Adjuvants Revenue by Application (2019-2030)
12.2.2 MEALA Vaccine Adjuvants Sales by Application (2019-2030)
12.2.3 MEALA Vaccine Adjuvants Price by Application (2019-2030)
12.3 MEALA Vaccine Adjuvants Market Size by Country
12.3.1 MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Vaccine Adjuvants Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Vaccine Adjuvants Value Chain Analysis
13.1.1 Vaccine Adjuvants Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Vaccine Adjuvants Production Mode & Process
13.2 Vaccine Adjuvants Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Vaccine Adjuvants Distributors
13.2.3 Vaccine Adjuvants Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
LIST OF TABLES
Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Aluminum Adjuvant Major Manufacturers
Table 3. Emulsions Adjuvant Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Vaccine Adjuvants Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Human Vaccine Major Manufacturers
Table 7. Veterinary Vaccine Major Manufacturers
Table 8. Vaccine Adjuvants Industry Trends
Table 9. Vaccine Adjuvants Industry Drivers
Table 10. Vaccine Adjuvants Industry Opportunities and Challenges
Table 11. Vaccine Adjuvants Industry Restraints
Table 12. Global Vaccine Adjuvants Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Vaccine Adjuvants Revenue Market Share by Region (2019-2024)
Table 16. Global Vaccine Adjuvants Revenue Market Share by Region (2025-2030)
Table 17. Global Vaccine Adjuvants Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (MT)
Table 18. Global Vaccine Adjuvants Sales by Region (2019-2024) & (MT)
Table 19. Global Vaccine Adjuvants Sales by Region (2025-2030) & (MT)
Table 20. Global Vaccine Adjuvants Sales Market Share by Region (2019-2024)
Table 21. Global Vaccine Adjuvants Sales Market Share by Region (2025-2030)
Table 22. Global Vaccine Adjuvants Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Vaccine Adjuvants Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Vaccine Adjuvants Sales Price (USD/Kg) of Manufacturers (2019-2024)
Table 27. Global Vaccine Adjuvants Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Vaccine Adjuvants Manufacturers, Product Type & Application
Table 30. Global Vaccine Adjuvants Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Vaccine Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Vaccine Adjuvants Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Vaccine Adjuvants Revenue Market Share by Type (2019-2024)
Table 37. Global Vaccine Adjuvants Revenue Market Share by Type (2025-2030)
Table 38. Global Vaccine Adjuvants Sales by Type 2019 VS 2023 VS 2030 (MT)
Table 39. Global Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 40. Global Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 41. Global Vaccine Adjuvants Sales Market Share by Type (2019-2024)
Table 42. Global Vaccine Adjuvants Sales Market Share by Type (2025-2030)
Table 43. Global Vaccine Adjuvants Price by Type (2019-2024) & (USD/Kg)
Table 44. Global Vaccine Adjuvants Price by Type (2025-2030) & (USD/Kg)
Table 45. Global Vaccine Adjuvants Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Vaccine Adjuvants Revenue Market Share by Application (2019-2024)
Table 49. Global Vaccine Adjuvants Revenue Market Share by Application (2025-2030)
Table 50. Global Vaccine Adjuvants Sales by Application 2019 VS 2023 VS 2030 (MT)
Table 51. Global Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 52. Global Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 53. Global Vaccine Adjuvants Sales Market Share by Application (2019-2024)
Table 54. Global Vaccine Adjuvants Sales Market Share by Application (2025-2030)
Table 55. Global Vaccine Adjuvants Price by Application (2019-2024) & (USD/Kg)
Table 56. Global Vaccine Adjuvants Price by Application (2025-2030) & (USD/Kg)
Table 57. GSK Company Information
Table 58. GSK Business Overview
Table 59. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 60. GSK Vaccine Adjuvants Product Portfolio
Table 61. GSK Recent Development
Table 62. CSL Limited Company Information
Table 63. CSL Limited Business Overview
Table 64. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 65. CSL Limited Vaccine Adjuvants Product Portfolio
Table 66. CSL Limited Recent Development
Table 67. Croda Company Information
Table 68. Croda Business Overview
Table 69. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 70. Croda Vaccine Adjuvants Product Portfolio
Table 71. Croda Recent Development
Table 72. SEPPIC Company Information
Table 73. SEPPIC Business Overview
Table 74. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 75. SEPPIC Vaccine Adjuvants Product Portfolio
Table 76. SEPPIC Recent Development
Table 77. Novavax Company Information
Table 78. Novavax Business Overview
Table 79. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 80. Novavax Vaccine Adjuvants Product Portfolio
Table 81. Novavax Recent Development
Table 82. SPI Pharma Company Information
Table 83. SPI Pharma Business Overview
Table 84. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 85. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 86. SPI Pharma Recent Development
Table 87. Phibro Company Information
Table 88. Phibro Business Overview
Table 89. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 90. Phibro Vaccine Adjuvants Product Portfolio
Table 91. Phibro Recent Development
Table 92. SDA BIO Company Information
Table 93. SDA BIO Business Overview
Table 94. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 95. SDA BIO Vaccine Adjuvants Product Portfolio
Table 96. SDA BIO Recent Development
Table 97. Invivogen Company Information
Table 98. Invivogen Business Overview
Table 99. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 100. Invivogen Vaccine Adjuvants Product Portfolio
Table 101. Invivogen Recent Development
Table 102. Tj Kaiwei Company Information
Table 103. Tj Kaiwei Business Overview
Table 104. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 105. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 106. Tj Kaiwei Recent Development
Table 107. OZ Biosciences Company Information
Table 108. OZ Biosciences Business Overview
Table 109. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 110. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 111. OZ Biosciences Recent Development
Table 112. Brenntag Biosector Company Information
Table 113. Brenntag Biosector Business Overview
Table 114. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 115. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 116. Brenntag Biosector Recent Development
Table 117. MVP Laboratories Company Information
Table 118. MVP Laboratories Business Overview
Table 119. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 120. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 121. MVP Laboratories Recent Development
Table 122. Zhuoyue Company Information
Table 123. Zhuoyue Business Overview
Table 124. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 125. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 126. Zhuoyue Recent Development
Table 127. Aphios Company Information
Table 128. Aphios Business Overview
Table 129. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 130. Aphios Vaccine Adjuvants Product Portfolio
Table 131. Aphios Recent Development
Table 132. North America Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 133. North America Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 134. North America Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 135. North America Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 136. North America Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 137. North America Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 138. North America Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 139. North America Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 140. North America Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 141. North America Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 142. North America Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 143. North America Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 144. North America Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 145. North America Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 146. North America Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 147. North America Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 148. North America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 149. North America Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 150. North America Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 151. North America Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 152. US Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 153. Canada Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 154. Europe Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 155. Europe Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 156. Europe Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 157. Europe Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 158. Europe Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 159. Europe Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 160. Europe Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 161. Europe Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 162. Europe Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 163. Europe Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 164. Europe Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 165. Europe Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 166. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 167. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 168. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 169. Europe Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 170. Europe Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 171. Europe Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 172. Europe Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 173. Europe Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 174. Germany Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 175. France Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 176. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 177. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 178. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 179. China Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 180. China Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 181. China Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 182. China Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 183. China Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 184. China Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 185. China Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 186. China Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 187. China Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 188. China Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 189. China Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 190. China Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 191. Asia Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 192. Asia Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 193. Asia Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 194. Asia Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 195. Asia Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 196. Asia Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 197. Asia Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 198. Asia Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 199. Asia Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 200. Asia Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 201. Asia Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 202. Asia Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 203. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 204. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 205. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 206. Asia Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 207. Asia Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 208. Asia Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 209. Asia Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 210. Asia Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 211. Japan Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 212. South Korea Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 213. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 214. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 215. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 216. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 217. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 218. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 219. MEALA Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 220. MEALA Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 221. MEALA Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 222. MEALA Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 223. MEALA Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 224. MEALA Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 225. MEALA Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 226. MEALA Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 227. MEALA Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 228. MEALA Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 229. MEALA Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 230. MEALA Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 231. MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 232. MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 233. MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 234. MEALA Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 235. MEALA Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 236. MEALA Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 237. MEALA Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 238. MEALA Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 239. Mexico Vaccine Adjuvants Revenue (2019-2030) & (US$
Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Aluminum Adjuvant Major Manufacturers
Table 3. Emulsions Adjuvant Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Vaccine Adjuvants Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Human Vaccine Major Manufacturers
Table 7. Veterinary Vaccine Major Manufacturers
Table 8. Vaccine Adjuvants Industry Trends
Table 9. Vaccine Adjuvants Industry Drivers
Table 10. Vaccine Adjuvants Industry Opportunities and Challenges
Table 11. Vaccine Adjuvants Industry Restraints
Table 12. Global Vaccine Adjuvants Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Vaccine Adjuvants Revenue by Region (2019-2024) & (US$ Million)
Table 14. Global Vaccine Adjuvants Revenue by Region (2025-2030) & (US$ Million)
Table 15. Global Vaccine Adjuvants Revenue Market Share by Region (2019-2024)
Table 16. Global Vaccine Adjuvants Revenue Market Share by Region (2025-2030)
Table 17. Global Vaccine Adjuvants Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (MT)
Table 18. Global Vaccine Adjuvants Sales by Region (2019-2024) & (MT)
Table 19. Global Vaccine Adjuvants Sales by Region (2025-2030) & (MT)
Table 20. Global Vaccine Adjuvants Sales Market Share by Region (2019-2024)
Table 21. Global Vaccine Adjuvants Sales Market Share by Region (2025-2030)
Table 22. Global Vaccine Adjuvants Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 23. Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
Table 24. Global Vaccine Adjuvants Sales by Manufacturers (US$ Million) & (2019-2024)
Table 25. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
Table 26. Global Vaccine Adjuvants Sales Price (USD/Kg) of Manufacturers (2019-2024)
Table 27. Global Vaccine Adjuvants Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 28. Global Vaccine Adjuvants Key Manufacturers Manufacturing Sites & Headquarters
Table 29. Global Vaccine Adjuvants Manufacturers, Product Type & Application
Table 30. Global Vaccine Adjuvants Manufacturers Commercialization Time
Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Vaccine Adjuvants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 33. Global Vaccine Adjuvants Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 34. Global Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Vaccine Adjuvants Revenue Market Share by Type (2019-2024)
Table 37. Global Vaccine Adjuvants Revenue Market Share by Type (2025-2030)
Table 38. Global Vaccine Adjuvants Sales by Type 2019 VS 2023 VS 2030 (MT)
Table 39. Global Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 40. Global Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 41. Global Vaccine Adjuvants Sales Market Share by Type (2019-2024)
Table 42. Global Vaccine Adjuvants Sales Market Share by Type (2025-2030)
Table 43. Global Vaccine Adjuvants Price by Type (2019-2024) & (USD/Kg)
Table 44. Global Vaccine Adjuvants Price by Type (2025-2030) & (USD/Kg)
Table 45. Global Vaccine Adjuvants Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Global Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 47. Global Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 48. Global Vaccine Adjuvants Revenue Market Share by Application (2019-2024)
Table 49. Global Vaccine Adjuvants Revenue Market Share by Application (2025-2030)
Table 50. Global Vaccine Adjuvants Sales by Application 2019 VS 2023 VS 2030 (MT)
Table 51. Global Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 52. Global Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 53. Global Vaccine Adjuvants Sales Market Share by Application (2019-2024)
Table 54. Global Vaccine Adjuvants Sales Market Share by Application (2025-2030)
Table 55. Global Vaccine Adjuvants Price by Application (2019-2024) & (USD/Kg)
Table 56. Global Vaccine Adjuvants Price by Application (2025-2030) & (USD/Kg)
Table 57. GSK Company Information
Table 58. GSK Business Overview
Table 59. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 60. GSK Vaccine Adjuvants Product Portfolio
Table 61. GSK Recent Development
Table 62. CSL Limited Company Information
Table 63. CSL Limited Business Overview
Table 64. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 65. CSL Limited Vaccine Adjuvants Product Portfolio
Table 66. CSL Limited Recent Development
Table 67. Croda Company Information
Table 68. Croda Business Overview
Table 69. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 70. Croda Vaccine Adjuvants Product Portfolio
Table 71. Croda Recent Development
Table 72. SEPPIC Company Information
Table 73. SEPPIC Business Overview
Table 74. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 75. SEPPIC Vaccine Adjuvants Product Portfolio
Table 76. SEPPIC Recent Development
Table 77. Novavax Company Information
Table 78. Novavax Business Overview
Table 79. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 80. Novavax Vaccine Adjuvants Product Portfolio
Table 81. Novavax Recent Development
Table 82. SPI Pharma Company Information
Table 83. SPI Pharma Business Overview
Table 84. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 85. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 86. SPI Pharma Recent Development
Table 87. Phibro Company Information
Table 88. Phibro Business Overview
Table 89. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 90. Phibro Vaccine Adjuvants Product Portfolio
Table 91. Phibro Recent Development
Table 92. SDA BIO Company Information
Table 93. SDA BIO Business Overview
Table 94. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 95. SDA BIO Vaccine Adjuvants Product Portfolio
Table 96. SDA BIO Recent Development
Table 97. Invivogen Company Information
Table 98. Invivogen Business Overview
Table 99. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 100. Invivogen Vaccine Adjuvants Product Portfolio
Table 101. Invivogen Recent Development
Table 102. Tj Kaiwei Company Information
Table 103. Tj Kaiwei Business Overview
Table 104. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 105. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 106. Tj Kaiwei Recent Development
Table 107. OZ Biosciences Company Information
Table 108. OZ Biosciences Business Overview
Table 109. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 110. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 111. OZ Biosciences Recent Development
Table 112. Brenntag Biosector Company Information
Table 113. Brenntag Biosector Business Overview
Table 114. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 115. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 116. Brenntag Biosector Recent Development
Table 117. MVP Laboratories Company Information
Table 118. MVP Laboratories Business Overview
Table 119. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 120. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 121. MVP Laboratories Recent Development
Table 122. Zhuoyue Company Information
Table 123. Zhuoyue Business Overview
Table 124. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 125. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 126. Zhuoyue Recent Development
Table 127. Aphios Company Information
Table 128. Aphios Business Overview
Table 129. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 130. Aphios Vaccine Adjuvants Product Portfolio
Table 131. Aphios Recent Development
Table 132. North America Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 133. North America Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 134. North America Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 135. North America Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 136. North America Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 137. North America Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 138. North America Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 139. North America Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 140. North America Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 141. North America Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 142. North America Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 143. North America Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 144. North America Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 145. North America Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 146. North America Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 147. North America Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 148. North America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 149. North America Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 150. North America Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 151. North America Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 152. US Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 153. Canada Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 154. Europe Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 155. Europe Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 156. Europe Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 157. Europe Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 158. Europe Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 159. Europe Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 160. Europe Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 161. Europe Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 162. Europe Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 163. Europe Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 164. Europe Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 165. Europe Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 166. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 167. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 168. Europe Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 169. Europe Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 170. Europe Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 171. Europe Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 172. Europe Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 173. Europe Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 174. Germany Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 175. France Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 176. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 177. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 178. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 179. China Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 180. China Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 181. China Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 182. China Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 183. China Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 184. China Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 185. China Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 186. China Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 187. China Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 188. China Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 189. China Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 190. China Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 191. Asia Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 192. Asia Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 193. Asia Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 194. Asia Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 195. Asia Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 196. Asia Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 197. Asia Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 198. Asia Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 199. Asia Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 200. Asia Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 201. Asia Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 202. Asia Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 203. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 204. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 205. Asia Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 206. Asia Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 207. Asia Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 208. Asia Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 209. Asia Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 210. Asia Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 211. Japan Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 212. South Korea Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 213. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 214. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 215. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 216. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 217. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 218. Vaccine Adjuvants Revenue (2019-2030) & (US$ Million)
Table 219. MEALA Vaccine Adjuvants Revenue by Type (2019-2024) & (US$ Million)
Table 220. MEALA Vaccine Adjuvants Revenue by Type (2025-2030) & (US$ Million)
Table 221. MEALA Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 222. MEALA Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 223. MEALA Vaccine Adjuvants Sales Price by Type (2019-2024) & (USD/Kg)
Table 224. MEALA Vaccine Adjuvants Sales Price by Type (2025-2030) & (USD/Kg)
Table 225. MEALA Vaccine Adjuvants Revenue by Application (2019-2024) & (US$ Million)
Table 226. MEALA Vaccine Adjuvants Revenue by Application (2025-2030) & (US$ Million)
Table 227. MEALA Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 228. MEALA Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 229. MEALA Vaccine Adjuvants Sales Price by Application (2019-2024) & (USD/Kg)
Table 230. MEALA Vaccine Adjuvants Sales Price by Application (2025-2030) & (USD/Kg)
Table 231. MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 232. MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 233. MEALA Vaccine Adjuvants Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 234. MEALA Vaccine Adjuvants Sales by Country (2019 VS 2023 VS 2030) & (MT)
Table 235. MEALA Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 236. MEALA Vaccine Adjuvants Sales by Country (2025-2030) & (MT)
Table 237. MEALA Vaccine Adjuvants Sales Price by Country (2019-2024) & (USD/Kg)
Table 238. MEALA Vaccine Adjuvants Sales Price by Country (2025-2030) & (USD/Kg)
Table 239. Mexico Vaccine Adjuvants Revenue (2019-2030) & (US$
